tiprankstipranks
Orchestra BioMed Holdings (OBIO)
NASDAQ:OBIO
US Market

Orchestra BioMed Holdings (OBIO) Income Statement

Compare
57 Followers

Orchestra BioMed Holdings Income Statement

Last quarter (Q3 2024), Orchestra BioMed Holdings's total revenue was $987.00K, an increase of 135.56% from the same quarter last year. In Q3, Orchestra BioMed Holdings's net income was $-15.43M. See Orchestra BioMed Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 2.76M$ 3.53M$ -782.00K$ 5.70M
Gross Profit
$ 2.57M$ 3.21M$ -981.00K$ 5.56M
Operating Expenses
$ 54.08M$ 35.87M$ 20.82M$ 24.31M
Depreciation and Amortization
$ 287.00K$ 222.00K$ 181.00K$ 137.00K
EBITDA
$ -51.22M$ -32.44M$ -21.62M$ -18.61M
Operating Income
$ -51.51M$ -32.66M$ -21.80M$ -18.75M
Other Income/Expenses
$ 2.39M$ -951.00K$ -1.22M$ -2.60M
Pretax Income
$ -49.12M$ -33.61M$ -23.01M$ -21.36M
Net Income
$ -49.12M$ -33.61M$ -23.01M$ -21.36M
Per Share Metrics
$ ―$ ―$ ―$ ―
Basic EPS
$ -1.48$ -2.24$ -1.13$ -1.04
Diluted EPS
$ -1.48$ -2.24$ -1.13$ -1.04
Weighted Average Shares Outstanding
33.23M 14.99M 20.45M 20.45M
Weighted Average Shares Outstanding (Diluted)
33.23M 14.99M 20.45M 20.45M
Currency in USD

Orchestra BioMed Holdings Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis